Atlas Private Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Atlas Private Wealth Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$23K	–	412
2020 Q3	$23K	Hold	200	–	–	0.02%	241
2020 Q2	$20K	Hold	200	–	–	0.02%	269
2020 Q1	$13K	Hold	200	–	–	0.01%	289
2019 Q4	$12K	Buy	+200	New	+$12.3K	0.01%	337

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Atlas Private Wealth Management's TNDM Position: Q4 2020 in Review

Atlas Private Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q4 2020, closing a stake of 200 shares — an estimated $23K sold.

Atlas Private Wealth Management first reported a position in TNDM in Q4 2019 and held it in 4 quarters. The position peaked at $23K in Q3 2020. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

Atlas Private Wealth Management reported no remaining Tandem Diabetes Care position as of Q4 2020 after selling out during the quarter.
Atlas Private Wealth Management sold 200 Tandem Diabetes Care shares in Q4 2020, an estimated $23K.
Atlas Private Wealth Management first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 4 quarters.
Atlas Private Wealth Management's Tandem Diabetes Care position peaked at $23K in Q3 2020.
309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on Atlas Private Wealth Management's 13F filing for Q4 2020, filed 27 Jan 2021.